WHO updates its treatment guidelines for MDR/RR-TB

The updated WHO treatment guidelines recommend that drug-resistant TB be treated with oral drugs only, including newer, more potent drugs with fewer side effects.

Read More →

Advocates call on Indian government to improve its response to drug-resistant TB

Advocates call for minimizing the use of injectable agents and scaling up universal drug susceptibility testing.

Read More →

Advocates call on Kenyan government to immediately address dangerous stock out of diagnostic tests for TB

Advocates call for removal of regulatory barriers, which contributed to the ongoing national stock out of GeneXpert MTB/RIF cartridges.

Read More →

Revamped WHO Civil Society Task Force

The World Health Organization has revamped its Civil Society Task Force on TB to strengthen collaboration for accelerating progress towards ending TB.

Read More →

AIDS, TB and malaria: Don't be infected by indifference: Sign a petition!

The petition will be delivered to the Heads of States and Governments prior to the next Global Fund replenishment conference in October 2019.

Read More →

New TAG report: Funding for TB research climbed to new high in 2017

Global funding for TB research climbed to a previously unreported high of USD $772 million in 2017.

Read More →

World TB Day 2019 theme announced

IT'S TIME... to get ready for World TB Day 2019!

Read More →

HIV and TB treatment at risk as countries gradually lose Global Fund support

Médecins Sans Frontières calls on Global Fund Board to make urgent changes to prevent drug stock-outs and quality issues.

Read More →

Urgent need to address the Global Fund procurement cliff for TB

Activists urge the Global Fund and donors to take prompt action to address the grave risks posed to countries that are rapidly shifting from pooled procurement of TB medicines and commodities.

Read More →

Rapid shift from global to national purchase of TB drugs increases risk of stockouts and use of drugs of unknown quality

Activists urge international donors and country governments to ensure access to quality health products as domestic financing policies push programs to the edge of procurement cliff.

Read More →

Page 1 of 95 · Total posts: 10

1 2 Last→